CORC

在结果中检索

CORC

浏览/检索结果: 共75条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：115/0  |  提交时间：2019/12/05
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study 期刊论文
CHEST, 2019, 卷号: 155, 期号: 1
作者:  Zhai, Zhenguo;  Kan, Quancheng;  Li, Weimin;  Qin, Xinyu;  Qu, Jieming
收藏  |  浏览/下载：63/0  |  提交时间：2019/12/05
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study 期刊论文
CHEST, 2019, 卷号: 155, 页码: 114-122
作者:  Zhai, Zhenguo;  Kan, Quancheng;  Li, Weimin;  Qin, Xinyu;  Qu, Jieming
收藏  |  浏览/下载：63/0  |  提交时间：2019/11/19
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303. 期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:  Si Xiaoyan;  Zhang Li;  Wang Hanping;  Zhang Xiaotong;  Wang Mengzhao
收藏  |  浏览/下载：35/0  |  提交时间：2019/11/19
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism -A Cross-sectional Study 期刊论文
CHEST, 2019, 卷号: Vol.155 No.1, 页码: 114-122
作者:  Zhai, Zhenguo;  Kan, Quancheng;  Li, Weimin;  Qin, Xinyu;  Qu, Jieming
收藏  |  浏览/下载：54/0  |  提交时间：2019/12/13
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：45/0  |  提交时间：2020/01/03
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study 期刊论文
2019, 卷号: 155, 期号: 1, 页码: 114-122
作者:  Zhai, Zhenguo;  Kan, Quancheng;  Li, Weimin;  Qin, Xinyu;  Qu, Jieming
收藏  |  浏览/下载：39/0  |  提交时间：2020/01/03
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
VisDrone-SOT2018: The vision meets drone single-object tracking challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Wen, Longyin;  Zhu, Pengfei;  Du, Dawei;  Bian, Xiao;  Ling, Haibin
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/30
The efficacy of anlotinib in squamous cell carcinoma (SCC) patients with or without hypertension in ALTER0303: Anlotinib as a third-line therapy in patients with advanced non-small cell lung cancer (NSCLC). 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Shi, Jianhua;  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/31

©版权所有 ©2017 CSpace - Powered by CSpace